PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20032083-0	2010	Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes.	Nitric Oxide	0-12	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	21-28	
29871907-8	2018	In vitro overexpression of SLC29A1 in human endothelial cells disrupted adenosine signaling and reduced nitric oxide levels that were further lowered upon bevacizumab exposure.Conclusions: The genomic region between SLC29A1 and HSP90AB1 and its role in regulating adenosine signaling are key targets for further investigation into the pathogenesis of bevacizumab-induced hypertension.	Nitric Oxide	104-116	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	27-34	
32858046-7	2020	Effects of adenosine A2 receptors antagonists and ENT1/2 inhibitor were prevented by L-NAME, indicating that nitric oxide production inhibition prevents adenosine from increasing parasitic burden.	Nitric Oxide	109-121	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	50-56	
20032083-1	2010	AIMS: Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes.	Nitric Oxide	94-106	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	34-72	
20032083-1	2010	AIMS: Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes.	Nitric Oxide	94-106	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	74-79	
20032083-1	2010	AIMS: Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes.	Nitric Oxide	94-106	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	130-137	
19193655-0	2009	TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.	Nitric Oxide	57-69	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	46-51	
19193655-2	2009	hENT1-mediated adenosine transport and expression are reduced in gestational diabetes and hyperglycaemia, conditions associated with increased synthesis and release of nitric oxide (NO) and TGF-beta1 in this cell type.	Nitric Oxide	168-180	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	0-5	
16688763-0	2006	Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes.	Nitric Oxide	0-12	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	43-47	
16688763-0	2006	Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes.	Nitric Oxide	0-12	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	54-61